The big unknown in the sleep apnea world continues to be when Philips will re-enter the market. ResMed has more than risen to the challenge of meeting unprecedented demand in the competitor's absence, but now medtech analysts are wondering if ResMed's sleep apnea market share gains are peaking.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,